News
These 3 are smaller than the competition, make no mistake they bring a lot to the table I used the words revenge of the...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow For almost a decade, I held research analyst positions in various investment firms, mostly in Toronto. In the...
News
This article was written by Follow I am an individual investor that is now fully focus on managing my own capital that I have...
News
This article was written by Follow I’m a full-time analyst and portfolio manager of a technology fund with 5 years of experience. I graduated...
News
Introduction Aldeyra Therapeutics (NASDAQ:ALDX) is a biotech firm focused on creating therapies for immune-mediated diseases. Their groundbreaking RASP (reactive aldehyde species) pharmaceutical platform targets...
News
On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB) and Eisai’s (OTCPK:ESALF, OTCPK:ESAIY) anti-amyloid antibody drug Leqembi. For...
News
China’s reopening has not gone as the bulls would’ve liked. Just take a look at the China Technology sector compared to the Nasdaq 100...
News
Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on June 25th, 2023....
News
Investment Thesis Green Thumb Industries (OTCQX:GTBIF) is one of the largest US multi-state operators (MSO) in the cannabis industry. They have the best balance...
News
Listen below or on the go on Apple Podcasts and Spotify. Matthew Tuttle and Rob Isbitts dissect the S&P, Nasdaq, and Dow’s poor index...
News
The CROX Investment Thesis Remains Excellent, Despite The Rally Thus Far CROX 3Y Stock Return Trading View Crocs, Inc. (NASDAQ:CROX) has delivered outstanding returns...
News
What’s the latest on Google stock? Playing catchup in AI Have you ever seen a football play where the offense snaps the ball while...
News
Last week’s article outlined expectations for bullish continuation in the S&P 500 (SPY). With the strong close to June and Q2, this was the...
